- SIGNA Experience is a new platform with solutions that work together to ensure a smooth scanning experience for the physician, technologist, and patient, with enhanced clinical efficiency
- The cornerstone of SIGNA Experience is SIGNA One, an imaging platform with a new user interface that enables intuitive workflow, efficiency, simplicity, and intelligent automation for the MRI scanning process
Chicago, US — November 27, 2022 - GE Healthcare today announced the launch of SIGNA Experie
business unit
Chicago, US – November 27, 2022 – Ahead of its planned spinoff from GE the first week of January 2023, GE Healthcare reveals over 40 solutions that aim to improve patient outcomes and increase healthcare efficiency at the Radiological Society of North America’s (RSNA) 2022 Annual Meeting.
For media inquiries, please contact:
Kyerstin HillExternal Affairs
GE Healthcare
+1 708 738 7741
[email protected]
business unit
tags
Chicago - November 23, 2022 – GE Healthcare announced today a $1 million donation of life-saving ultrasound and monitoring equipment to Ukraine as the ongoing war continues to take a heavy toll on the country’s healthcare system.
business unit
BOSTON – November 22, 2022 – General Electric Company (“GE”) (NYSE: GE) announced today that GE Healthcare Holding LLC (“GE HealthCare”), a direct, wholly-owned subsidiary of GE, has closed its previously announced offering of $1,000,000,000 aggregate principal amount of 5.550% senior notes due 2024 (the “2024 notes”), $1,500,000,000 aggregate principal amount of 5.600% senior notes due 2025 (the “2025 notes”) and $1,750,000,000 aggregate principal amount of 5.650% senior notes due 2027 (the “2027 notes” and, together with the 2024 notes and the 20
business unit
tags
- Intelligent workload management solution for PACS helps radiologists streamline workflow and can increase interpretation production by up to 21%. 1
- Imaging 360 Platform for Operations reduces patient backlog and AIR Recon DL helps enable up to 50% reduction in scan time to provide a better patient experience and clinician productivity.
business unit
- GE Healthcare’s design for Deep Silicon detectors for a photon counting CT (PCCT) is engineered with the goal of achieving breakthroughs in both CT spatial and spectral resolution at the same time and increasing imaging performance across care areas
- Researchers at the University of Wisconsin–Madison will kick off research scanning human subjects with GE Healthcare’s latest generation PCCT prototype in December 2022, representing the first U.S.
For media inquiries, please contact:
Margaret Steinhafel
1 608 381 8829
[email protected]
business unit
- Capacity expansion at Active Pharmaceutical Ingredient facility in Lindesnes, Norway, contributes to GE Healthcare’s aim to produce 30 million more doses of contrast media per year by 2025
- This step reinforces GE Healthcare’s broader commitment to address growing future demand for contrast media, which it expects to double in the next ten years
Lindesnes, 17 November 2022: GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingred